This study dynamically observed the changes in depression, anxiety, and fatigue of 118 chronic hepatitis B (CHB) patients who had been receiving nucleoside (acid) drug (NA) treatment for a long time before and after 104 weeks. The results showed that the overall improvement of the three psychological symptoms was significant (P<0.05), confirming that antiviral treatment has a positive impact on mental health. However, subgroup analysis found that it was more difficult for those with liver cirrhosis and family history of liver cancer to relieve fatigue; the anxiety relief rate was lower for women, those with a family history of liver cancer, and those with low education levels; women and family history of liver cancer were the main risk factors for persistent depression. Multivariate Logistic regression further quantified the effect values of various risk factors (such as the OR for liver cancer family history on depression relief was 0.091, P=0.003). The study emphasizes that the improvement of psychology is not homogeneous and it is necessary to identify high-risk populations for stratified intervention.